Healthcare
Concord Biotech Limited (CONCORDBIO)
Concord Biotech Limited (CONCORDBIO) is an NSE-listed Healthcare company. latest close ₹1,330.8, 1-day return -2.1%, 1-week return -3.1%. This page shows price, returns, and technical signals from QUANTSCASE. Informational only — not investment advice.
Data as of 7 Oct 2026
For informational and educational purposes only. Not investment advice. QUANTSCASE is a stock screener, not a SEBI-registered investment adviser, research analyst, or portfolio manager. Terms
Price & returns
- Last close
- ₹1,330.8
- 1-day return
- -2.1%
- 1-week return
- -3.1%
- 1-month return
- -9.5%
Technical signals
Latest daily indicators. These are screen readings, not buy or sell calls.
- RSI (14)
- 34.4
- ADX (14)
- 55.3
- ROC 10
- -14.7%
- vs 52W high
- -20.2%
Fundamentals snapshot
Latest fields from our NSE fundamentals table. Figures can lag the live tape.
- Market cap
- ₹14,636 Cr
- P/E
- 48.3
- P/B
- 7.26
- ROE
- —
- D/E
- 0.12
- Net margin
- 24.8%
- Rev. growth YoY
- 26.2%
- Div. yield
- 55.0%
- 52W high
- ₹1,647.8
- 52W low
- ₹987
- EPS (TTM)
- ₹28.98
Live signals
Built from the latest price, 1-day / 1-week return, and technical snapshot — not a news calendar.
- signal
1-day return -2.1%
Latest 1-day price change versus the previous close.
- signal
1-week return -3.1%
Price change over the last five trading sessions.
- signal
SuperTrend is down
Daily SuperTrend direction is down on the latest technicals refresh.
- signal
ADX(14) 55 — trend in force
ADX above 25 usually means a directional move is underway.
News & screener mentions
Recent QUANTSCASE daily posts that listed CONCORDBIO.
No recent screener posts mentioned CONCORDBIO yet. New daily posts will show up here automatically.
